A study analyzed the geographic and institutional disparities in clinical trial distribution for candidates targeting the ...

VX01-DR-201, is a phase 2, multi-center, double-masked, randomized, placebo-controlled study in patients with moderate to ...

With vision loss due to diabetes emerging as one of the most serious yet overlooked complications in India, Firstpost brings ...

Oculis has concluded subject enrolment for the Phase III clinical trials of OCS-01 eye drops for diabetic macular oedema.

India holds the unenviable position of being home to the world’s largest diabetic population, with nearly 100 million ...

Pars plana vitrectomy is a safe and effective surgery that is essential in the treatment of a variety of posterior segment ...

The global Diabetic Retinopathy Market is valued at USD 9.1 Billion in 2024 and is projected to reach a value of USD 15.1 ...

Emergen Research Logo The development of anti-VEGF therapies, which inhibit the growth of abnormal blood vessels in the retina, reduces the ...